Company:  APYX MEDICAL CORP (APYX)
Form Type:  10-Q
Filing Date:  5/8/2019 
CIK:  0000719135 
Address:  5115 ULMERTON ROAD 
City, State, Zip:  CLEARWATER, Florida 33760 
Telephone:  (727) 384-2323 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$6.31  
Change: 
-0.01 (-0.16%)  
Trade Time: 
Jul 19  
Market Cap: 
$214.03M
Trade APYX now with 

© 2019  
Description of Business
Apyx Medical Corporation ("Company", "Apyx Medical", "we", "us", or "our"), formerly known as Bovie Medical Corporation, was incorporated in 1982, under the laws of the State of Delaware and has its principal executive office at 5115 Ulmerton Road, Clearwater, FL 33760. We are a medical technology company and the developer of J-Plasma® (marketed and sold under the Renuvion(TM) Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers.
Register and access this filing in:     
  FORM 10-Q
    PART I. Financial Information
      ITEM 1. Financial Statements
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
        NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2. Management's Discussion and Analysis of Financial ...
      ITEM 3. Quantitative and Qualitative Disclosures about ...
      ITEM 4. Controls and Procedures
    PART II. Other Information
      ITEM 1. Legal Proceedings
      ITEM 1A. Risk factors
      ITEM 2. Unregistered Sales of Equity Securities and Use of ...
      ITEM 3. Defaults Upon Senior Securities
      ITEM 4. Mine Safety Disclosures
      ITEM 5. Other Information
      ITEM 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
  EXHIBIT 31.2
  EXHIBIT 32.1
    CERTIFICATION OF CEO
  EXHIBIT 32.2
    CERTIFICATION OF CFO